# FDA recall D-1401-2012

> **Watson Laboratories Inc** · Class III · drug recall initiated 2012-04-17.

## Product

Loxapine Capsules USP, 25mg, 100 count bottle, Rx only, Manufactured By: Watson Laboratories Inc., Corona, CA 92880  NDC #  0591-0371-01

## Reason for recall

Labeling: Incorrect or Missing Package Insert:  An outdated version of a patient outsert was used when packaged.

## Distribution

Nationwide.

## Key facts

- **Recall number:** D-1401-2012
- **Recalling firm:** Watson Laboratories Inc
- **Classification:** Class III
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2012-04-17
- **Report date:** 2012-07-11
- **Termination date:** 2013-03-18

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Corona, CA, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-1401-2012

## Citation

> AI Analytics. FDA recall D-1401-2012. Retrieved 2026-05-25 from https://api.ai-analytics.org/recall/D-1401-2012. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*